企业入驻搜索写评价分类关于
简体中文English

Scott

美国

1 评价
8 被浏览
0 有帮助

1 条评价

MEDvidi

TWO MONTHS w/out urgently needed documentation

Nearly two months ago, I had my initial telehealth ADHD visit with MEDvidi. The appointment seemed to go pretty well and my overall opinion of MEDvidi continued to be fairly positive. But I still have not received the written diagnosis and treatment plan that I understood would follow soon after my appointment. This has been especially frustrating for me because they diagnosed me with adult ADHD (a life-changing event), I explained that I urgently needed documentation for active legal matters, and I began following up the next day. Instead, they have demanded that I pay them an additional fee and sign their HIPAA form that seems unusually worded, before providing me with my written diagnosis and treatment plan, even though I was not asking MEDvidi to send anything to a third party. In one call with a MEDvidi representative the call abruptly ended when I asked where those requirements appeared on the website, and in another conversation I was told that other staff were not properly trained. MEDvidi also required full payment upfront when I booked my appointment, but I did not even receive a receipt at first. I had to send multiple emails and make a phone call over about two weeks, before I eventually received billing documentation in the form of a "superbill" that I believe is inaccurate. I have also not received a refund despite asking for one. I am also concerned that MEDvidi provides services to people dealing with serious mental health issues such as anxiety, depression, and ADHD, but their somewhat hidden AI disclosure states that: “Users should be aware that they are communicating with an automated system and not a human representative.” I am sharing this information because, in my experience, dealing with MEDvidi has been highly frustrating and stressful, taken substantial time and attention away from other important projects and deadlines, and I think others may want to consider that when deciding whether to use MEDvidi’s service.

2026-08-03